Whether aluminum in the diet can cause Alzheimer’s disease remains controversial.^{3 4} Until this issue is resolved, it seems prudent for healthy people to take steps to minimize exposure to this unnecessary and potentially toxic metal. This can be done by reducing intake of foods cooked in aluminum pots, foods that come into direct contact with aluminum foil, and beverages stored in aluminum cans. Some water authorities add aluminum to the water supply to prevent the accumulation of particulate matter in the water. In such areas, bottled water may be preferable. It appears most unlikely, however, that avoidance of aluminum exposure after the diagnosis of Alzheimer’s disease could significantly affect the course of the disease.

Preliminary evidence has linked populations at high risk for Alzheimer’s disease with higher levels of dietary fat and calories; similarly, fish intake has been linked with low-risk populations.^{5 6 7} Whether these foods can actually increase or reduce the risk of Alzheimer’s disease, however, remains unknown.

Phosphatidylserine, which is related to lecithin, is a naturally occurring compound present in the brain. Though it is clearly not a cure, phosphatidylserine (100 mg three times per day) has been shown to improve mental function (such as ability to remember names and ability to recall the location of frequently misplaced objects) in individuals with Alzheimer’s disease.⁸ However, the phosphatidylserine used in these studies was obtained from the brain of cows, which at least in England has been found to sometimes be infected with a virus that could cause Creutzfeldt-Jakob syndrome, a rare and fatal disease in humans. A totally safe plant source of phosphatidylserine is also available—however, this is a different form of phosphatidylserine, and its effectiveness has not yet been documented.⁹

Large amounts of vitamin E may slow the progression of Alzheimer’s disease, according to researchers from the Alzheimer’s Disease Cooperative Study. A two-year double blind study of 341 individuals with Alzheimer’s disease of moderate severity found that 2,000 IU per day of vitamin E extended the time patients were able to care for themselves (such as bathing, dressing, and other necessary daily functions), compared with patients taking a placebo.¹⁰ Preliminary evidence has linked people who use antioxidant supplements (vitamins E or C) to a lower risk of Alzheimer’s disease compared with people not taking supplements.¹¹ Other preliminary research shows that higher blood levels of vitamin E correlate with better brain functioning in middle-aged and older adults.¹² The link between antioxidants and protection might make sense because in conditions related to Alzheimer’s disease, oxidative damage appears to be part of the disease process.¹³

Huperzine A is a substance first found in Huperzia serrata, a Chinese medicinal herb. In a well-designed, placebo-controlled trial, 58% of people with Alzheimer’s disease had significant improvement in memory and cognitive and behavioral functions after taking 200 mcg of huperzine A twice per day for eight weeks—a statistically significant improvement over the 36% who responded to placebo.²¹ Another double blind report using injected huperzine A confirmed a positive effect in people with dementia, including, but not limited to, Alzheimer’s disease.²²

Mitochondrial function appears to be impaired in people with Alzheimer’s disease. Due to its effects on mitochondrial functioning, one group of researchers has given coenzyme Q10 (along with iron and vitamin B6) to several people with Alzheimer’s disease and reported that the progression of the disease was prevented for one and a half to two years.²³ Research

Preliminary research had suggested that people with Alzheimer’s disease should avoid zinc supplements.²⁴ More recently, preliminary evidence in four patients actually showed improved mental function with zinc supplementation.²⁵ In a convincing review of the zinc/Alzheimer’s disease research, perhaps the most respected zinc researcher in the world concluded that zinc does not cause or exacerbate Alzheimer’s disease symptoms.²⁶

A small uncontrolled study showed that oral NADH improved mental function in people with Alzheimer’s disease.²⁷

Some researchers have found links between Alzheimer’s disease and evidence of vitamin B12 and folic acid deficiencies,²⁸ while others consider the problem to be of only minor significance.²⁹ Little is known about whether supplementation with either vitamin would significantly help people with this disease. Nonetheless, it makes sense for people with Alzheimer’s disease to be medically tested for vitamin B12 and folate deficiencies and to be treated if they are deficient.

Are there any side effects or interactions? Refer to the individual supplement for information about any side effects or interactions

Herbs that may be helpful

An extract made from the leaves of the Ginkgo biloba tree is a leading treatment for early-stage Alzheimer’s disease in Europe. While not a cure for this serious condition, Ginkgo biloba extract (GBE) may improve memory and quality of life and slow progression in the early stages of the disease. In addition, three double blind studies have shown that GBE is helpful for people in early stages of Alzheimer’s disease, as well as the closely related multi-infarct dementia.^{30 31 32} Patients with other types of dementia, including problems due to poor blood flow to the brain, also respond to GBE.

The tonic, or adaptogenic, class of herb is often used traditionally for elderly persons experiencing mental decline, although this use does not have scientific studies to support it. Examples include Asian ginseng (100–200 mg per day of the standardized herbal extract), eleuthero (Siberian ginseng) (2–3 grams per day of the dried root or 300–400 mg per day of the concentrated solid extract standardized on eleutherosides B and E), astragalus (two to three 500 mg capsules three times per day).

 Asian ginseng has the longest history of use in traditional Chinese medicine and is commonly used for older individuals showing signs of memory loss. Asian ginseng improves and sharpens mental concentration and performance, including attention and memory.^{34 35} While not as thoroughly researched as GBE for this condition, studies show that ginseng is effective at improving memory and also countering depression in the elderly. Some herbal supplements combine GBE with Asian ginseng.

Are there any side effects or interactions? Refer to the individual herb for information about any side effects or interactions.

For maximum absorption, take supplements with meals.

Big Savings on Health Supplements

This Month Specials

References:

1. Priest ND. Satellite symposium on Alzheimer’s disease and dietary aluminum. Proc Nutr Soc 1993;52:231–40.
2. Munoz DG. Is exposure to aluminum a risk factor for the development of Alzheimer disease?—No. Arch Neurol 1998;737–39 [review].
3. Munoz DG. Is exposure to aluminum a risk factor for the development of Alzheimer disease?—No. Arch Neurol 1998;55:737–39.
4. Forbes WF, Hill GB. Is exposure to aluminum a risk factor for the development of Alzheimer disease?—Yes.Arch Neurol 1998;55:740–41.
5. Grant WB. Dietary links to Alzheimer’s disease. Alz Dis Rev 1997;2:42–55.
6. Smith MA, Petot GJ, Perry G. Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer’s disease. Alz Dis Rev 1997;2:58–59.
7. Kalmijn S, Lauher LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol 1997;42:776–82.
8. Crook T et al. Effects of phosphatidylserine in Alzheimer’s disease. Psychopharmacol Bull 1992;28:61–66.
9. Gindin J, Novickov M, Kedar D, et al. The effect of plant phosphatidylserine on age-associated memory impairment and mood in the functioning elderly. Rehovot, Israel: Geriatric Institute for Education and Research, and Department of Geriatrics, Kaplan Hospital, 1995.
10. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med 1997;336:1216–22.
11. Morris MC, Beckett LA, Scherr PA, et al. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alz Dis Assoc Disorders 1998;12:121–26.
12. Schmidt R, Hayn M, Reinhart B, et al. Plasma antioxidants and cognitive performance in middle-aged and older adults: results of the Austrian Stroke Prevention Study. J Am Geriatr Soc 1998;46:1407–10.
13. Lethem R, Orrell M. Antioxidants and dementia. Lancet 1997;349:1189–90 [commentary].
14. Ferris SH, Sathananthan G, Gershon S, et al. Senile dementia. Treatment with Deanol. J Am Ger Soc 1977;25:241–44.
15. Fisman M, Mersky H, Helmes E. Double-blind trial of 2-dimethylaminoethanol in Alzheimer’s disease. Am J Psych 1981;138:970–72.
16. Pettegrew JW, Klunk WE, Panchalingam K, et al. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer’s disease. Neurobio Aging 1995;16:1–4.
17. Salvioli G, Neri M. L-acetylcarnitine treatment of mental decline in the elderly. Drugs Exp Clin Res 1994;20:169–76.
18. Cucinotta D et al. Multicenter clinical placebo-controlled study with acetyl-L-carnitine (LAC) in the treatment of mildly demented elderly patients. Drug Development Res 1988;14:213–16.
19. Thal LJ, Carta A, Clarke WR, et al. A 1-year multi-center placebo-controlled study of aceyl-L-carnitine in patients with Alzheimer’s disease. Neurol 1996;47:705–11.
20. Calvani M, Carta A, Caruso G, et al. Action of acetyl-L-carnitine in neurodegeneration and Alzheimer’s disease. Ann NY Acad Sci 1992;663:483–86.
21. Xu SS, Gao ZX, Weng Z, et al. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer’s disease. Chung Kuo Yao Li Hsueh Pao 1995;16:391–95.
22. Zhang RW, Tang XC, Han YY, et al. Drug evaluation of huperzine A in the treatment of senile memory disorders. Chung Kuo Yao Li Hsueh Pao 1991;12:250–52 [in Chinese].
23. Imagawa M, Naruse S, Tsuji S, et al. Coenzyme Q10, iron, and vitamin B6 in genetically-confirmed Alzheimer’s disease. Lancet 1992;340:671 [letter].
24. Bush AI, Pettingell WH, Multhaup G, et al. Rapid induction of Alzheimer A8 amyloid formation by zinc. Science 1994;265:1464–65.
25. Potocnik FCV, van Rensburg SJ, Park C, et al. Zinc and platelet membrane microviscosity in Alzheimer’s disease. S Afr Med J 1997;87:1116–19.
26. Prasad AS. Zinc in human health: an update. J Trace Elements Exper Med 1998;11:63–87.
27. Birkmayer JGD. Coenzyme nicotinamide adenine dinucleotide: New therapeutic approach for improving dementia of the Alzheimer type. Ann Clin Lab Sci 1996;26:1–9.
28. Clarke R, Smith D, Jobst KA, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449–55.
29. Joosten E, Lesaffre E, Riezler R, et al. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer’s disease? J Gastroenterol 1997;52A:M76–M79.
30. Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 1997;278:1327–32.
31. Hofferberth B. The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type, a double-blind, placebo-controlled study on different levels of investigation. Human Psychopharmacol 1994;9:215–22.
32. Kanowski S, Herrmann W, Stephan K, et al. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 1996;29:47–56.
33. Bhattacharya SK, Kumar A, Ghosal S. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer’s disease and perturbed central cholinergic markers of cognition in rats. Phytother Res 1995;9:110–13.
34. D’ Angelo L, Grimaldi R, et al. A double-blind, placebo-controlled clinical study of a standardized ginseng extract on psychomotor performance in healthy volunteers. J Ethnopharmacol 1986;16:15–22.
35. Owen RT. Ginseng–a pharmacological profile. Drugs Today 1981;17:343–51.